Compare TSHA & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TSHA | TTI |
|---|---|---|
| Founded | 2019 | 1981 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | N/A | N/A |
| Metric | TSHA | TTI |
|---|---|---|
| Price | $4.67 | $11.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $10.56 | $10.40 |
| AVG Volume (30 Days) | ★ 2.4M | 1.7M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.43 |
| Revenue Next Year | N/A | $4.18 |
| P/E Ratio | ★ N/A | $12.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.05 | $2.03 |
| 52 Week High | $6.02 | $12.54 |
| Indicator | TSHA | TTI |
|---|---|---|
| Relative Strength Index (RSI) | 48.31 | 51.71 |
| Support Level | $4.45 | $10.50 |
| Resistance Level | $4.80 | $11.98 |
| Average True Range (ATR) | 0.24 | 0.67 |
| MACD | 0.02 | -0.17 |
| Stochastic Oscillator | 60.61 | 32.99 |
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.